FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Zyprexa | Eli Lilly | Canada | antipsychotics

Court won't limit Canadian Zyprexa claims

Tools

Ontario’s highest court denied Eli Lilly's bid to limit potential damages in a lawsuit filed by Canadian patients, who claimed they developed diabetes after using the Zyprexa antipsycyotic. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about Zyprexa   Eli Lilly   Canada   antipsychotics  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.